(Q37994253)

26 August 2017

title

Cardiovascular health in the menopausal woman: impact of the timing of hormone replacement therapy (English)

1 reference

26 August 2017

1 reference

G Rosano

1

1 reference

26 August 2017

C Vitale

series ordinal

2

1 reference

26 August 2017

I Spoletini

series ordinal

3

1 reference

26 August 2017

M Fini

series ordinal

4

1 reference

26 August 2017

publication date

16 March 2012

1 reference

26 August 2017

1 reference

26 August 2017

volume

15

1 reference

26 August 2017

issue

4

1 reference

26 August 2017

page(s)

299-305

1 reference

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

26 August 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2012.658899

Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2012.658899

Postmenopausal hormone therapy and mortality.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2012.658899

A prospective, observational study of postmenopausal hormone therapy and primary prevention of cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2012.658899

Postmenopausal estrogen therapy and cardiovascular disease. Ten-year follow-up from the nurses' health study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2012.658899

Hormone therapy to prevent disease and prolong life in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2012.658899

Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II)

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2012.658899

Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2012.658899

Main morbidities recorded in the women's international study of long duration oestrogen after menopause (WISDOM): a randomised controlled trial of hormone replacement therapy in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2012.658899

Estrogen plus progestin and the risk of coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2012.658899

Estrogen plus progestin and risk of venous thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2012.658899

Effect of estrogen plus progestin on stroke in postmenopausal women: the Women's Health Initiative: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2012.658899

Combined analysis of Women's Health Initiative observational and clinical trial data on postmenopausal hormone treatment and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2012.658899

Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2012.658899

Brief report: Coronary heart disease events associated with hormone therapy in younger and older women. A meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2012.658899

Observational studies analyzed like randomized experiments: an application to postmenopausal hormone therapy and coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2012.658899

Current controversies regarding the cardiovascular effects of hormone therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2012.658899

Hormone replacement therapy and cardiovascular health in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2012.658899

Prior to use of estrogen replacement therapy, are users healthier than nonusers?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2012.658899

Controversies about HRT--lessons from monkey models

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2012.658899

Hormone therapy and the progression of coronary-artery atherosclerosis in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2012.658899

Effects of hormone replacement therapy and antioxidant vitamin supplements on coronary atherosclerosis in postmenopausal women: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2012.658899

Estrogen in the prevention of atherosclerosis. A randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2012.658899

Estrogen therapy and coronary-artery calcification.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2012.658899

Oophorectomy, hormone therapy, and subclinical coronary artery disease in women with hysterectomy: the Women's Health Initiative coronary artery calcium study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2012.658899

Time since menopause influences the acute and chronic effect of estrogens on endothelial function

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2012.658899

Understanding the divergent data on postmenopausal hormone therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2012.658899

Hormone replacement therapy and risk of venous thromboembolism in postmenopausal women: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2012.658899

Oral but not transdermal estrogen replacement therapy changes the composition of plasma lipoproteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2012.658899

Influence of age and menopause on serum lipids and lipoproteins in healthy women.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2012.658899

Levels of sex steroid and cardiovascular disease measures in premenopausal and hormone-treated women at midlife: implications for the "timing hypothesis"

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2012.658899

Molecular and cellular basis of cardiovascular gender differences

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2012.658899

Effect of hormone replacement therapy on vasomotor function of the coronary microcirculation in post-menopausal women with medically treated cardiovascular risk factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2012.658899

Hot flushes, coronary heart disease, and hormone therapy in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2012.658899

Vasomotor symptoms and cardiovascular events in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2012.658899

ACOG Committee Opinion No. 420, November 2008: hormone therapy and heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2012.658899

Estrogen and progestogen use in postmenopausal women: July 2008 position statement of The North American Menopause Society

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2012.658899

Using basic science to design a clinical trial: baseline characteristics of women enrolled in the Kronos Early Estrogen Prevention Study (KEEPS)

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2012.658899

Venous Thrombosis and Conjugated Equine Estrogen in Women Without a Uterus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2012.658899

Postmenopausal Estrogen and Progestin Use and the Risk of Cardiovascular Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2012.658899

10.3109/13697137.2012.658899

21 January 2018

Identifiers

DOI

1 reference

26 August 2017

1 reference